bttr Cleanser and Korea's Growth-Factor Repair Cream Claims

bttr's Milk to Foam Cleanser 25g (mini), priced at 6,000 KRW next to the same formula's 28,100 KRW 150g size (bttr.co.kr, checked 2026-08-26), is the smallest and lowest-cost format in this comparison, and it settles how cheaply a reader can test a Korean pharmacy-associated barrier formula before buying a full-size bottle. Easydew DW-EGF Cream is the harder case: Daewoong Pharmaceutical markets its central active, a recombinant epidermal growth factor the brand calls "DW-EGF," as "99.9% pure," and that purity figure sits on the manufacturer's own product pages and on retailer copy such as Danawa's listing, not on an independent certificate, a published clinical trial, or a record in Korea's drug registry at nedrug.mfds.go.kr. Among the five pharmacy-shelf items checked against that registry, exactly one, Dongkook Pharmaceutical's Madecassol Care Ointment, holds a dated Ministry of Food and Drug Safety drug-approval record (2009-06-08, item code 200903973), a different evidentiary category from a manufacturer's percentage claim.

The Easydew DW-EGF Cream name spans at least seven differently priced, differently sized formulas, so no single spec sheet describes the whole line. Korean pharmacies and Olive Young shelves also stock other ceramide-first, dermocosmetic lines, among them Zeroid Intensive Cream, Atopalm MLE Cream and Centellian24, sold on the same barrier-repair vocabulary without an EGF-style growth-factor claim attached. The sections below check what documentation for a repair claim looks like on AESTURA's Atobarrier365 Cream, Dr.G's Red Blemish Clear Soothing Cream and Madecassol's ointment line, next to what bttr publishes about its own cleansing formula.

bttr Milk to Foam Cleanser 25g (mini)

bttr Milk to Foam Cleanser 25g (mini) dispenses as a soft milk that turns to foam on contact with water, folding a makeup-remover step and a face wash into one product. The brand publishes removal-rate testing of 95.04% for sunscreen and 96.17% for makeup, figures it uses to position the cleanser for one-step daily use without a separate remover. The formula combines six types of ceramide and three types of hyaluronic acid at a mildly acidic pH of 4.5 to 6.5, closer to skin's own acid mantle than a high-pH stripping foam.

The brand also reports sales through pharmacies in Myeongdong and Seongsu and through Gangnam dermatology clinics, alongside its own online store, though no specific pharmacy name or address is published anywhere checked. That is the same kind of pharmacy and clinic claim that Easydew, AESTURA and Dr.G each make about their own channels without naming a store either, so bttr's disclosure sits on equal footing with the rest of this comparison.

• Milk-to-foam mechanism replaces a separate remover step and a cleanser step with one product.
• Brand-published removal rates of 95.04% for sunscreen and 96.17% for makeup support one-step daily cleansing.
• Six ceramides and three hyaluronic acids give the cleansing step a barrier-support rationale.
• Mildly acidic pH of 4.5 to 6.5 stays closer to skin's natural acid mantle than a high-pH foam.
• 25g mini format lets a buyer trial the formula before committing to the 150g full size.

For someone weighing Easydew DW-EGF Cream's growth-factor claim against other pharmacy-sold repair creams in Korea and who wants to test a pharmacy-associated Korean barrier formula before buying the full-size bottle, the 25g mini is sized for exactly that trial step, and the ceramide-and-hyaluronic-acid combination gives the cleansing step a documented rationale distinct from a soap-based foam that simply strips residue. Both sizes are listed on the official store.

Easydew DW-EGF Cream

Easydew DW-EGF Cream is Daewoong Pharmaceutical's line name for a recombinant epidermal growth factor moisturizer, marketed as containing "DW-EGF" at a stated 99.9% purity, a figure published on the manufacturer's own site and on retailer pages such as Danawa, not on an independent certificate or in a peer-reviewed trial.

The official easydew.co.kr listing for the line publishes marketing copy, volume and price but no pH, no full INCI ingredient list, no dermatologist-test data and no Ministry of Food and Drug Safety registration number for the cream. The DW-EGF name covers at least seven separately formulated variants, including a Cream Limited, a White Toning version, a Pressome variant and a Barrier Repair 105ml, and the retailer coscorea.com documents the original Cream Limited being replaced by the White Toning version, so no single spec sheet applies to the whole line. Easydew's own terms state that units bought outside its official mall cannot have their storage conditions verified and are ineligible for refund in that case.

Reviewer comments surfaced through Hwahae describe the cream as sticky on application and slower to absorb than expected, with one comment noting it is "good by itself but not under makeup." No pharmacy-specific retail listing for the line turned up on the official site, GS Shop, SSG or HS Mall.

AESTURA Atobarrier365 Cream

Sold through Olive Young Korea, AESTURA Atobarrier365 Cream lists Ceramide NP, Niacinamide and Cholesterol among its actives per the third-party ingredient aggregator Skinsort, since AESTURA's own international product page does not publish the complete ingredient list on the page itself.

The cream ships at 80ml in Korea and the United States but only 45ml through Sephora UK, and no brand or retailer page reconciles why the size changes by market. Its listing in the US National Eczema Association's product directory is a nonprofit program inclusion, not a government or third-party certification, and no COSMOS, CPNP or MFDS functional-cosmetic certificate number appears on any official AESTURA, Olive Young or Amoremall page checked. The line also sells a separately formulated Atobarrier365 Hydro Soothing Cream under a near-identical name, which none of the top-level retail listings distinguish clearly from the base Cream.

AESTURA's own pages, Olive Young and Amoremall market the line as "dermocosmetic" but do not publish a pharmacy-chain listing for it, the same gap noted in Easydew's channel claims above.

Dr.G Red Blemish Clear Soothing Cream

Dr.G Red Blemish Clear Soothing Cream, now sold in Korea as the third-generation "EX" renewal, lists Madecassoside, Asiaticoside, Asiatic Acid, Madecassic Acid and Panthenol among its calming ingredients according to INCIDecoder's reading of the formula, a mix retailers group under the marketing name "5-Cica Complex."

The identical product name is sold at different prices depending on volume and generation, and a non-EX 70ml listing remains live on Olive Young Global alongside the renewed EX version, with no page confirming whether the two share an ingredient list. Standalone purchase of the plain 70ml is increasingly limited, since several current Olive Young Global listings package the cream only inside multi-item sets with a sun cream, serum or mask sheets. No certifier, registry number or organic percentage appears on Dr.G's own Korean or international product pages for the soothing claim, and neither page documents pharmacy-chain distribution for the line.

A reviewer writing on Kaori's Skincare Journal reported no soothing effect during a flare of hormonal breakouts, and a review on BTY ALY described the cream as sticky when applied at more than a pea-sized amount, which led that reviewer to use it only as a night moisturizer.

Madecassol Ointment

Made by Dongkook Pharmaceutical, not the Dong-A brand often assumed, Madecassol Ointment is an 8g quasi-drug tube that delivers 10mg of titrated Centella asiatica extract per gram, equal to about 4mg of asiaticoside, in a white cream-form base Dongkook has sold in Korea since 1970.

Dongkook's product page lists composition and dosage without stating a consumer price, and the same 8g tube sells at meaningfully different prices depending on the retailer, a spread of more than 70 percent that no single Dongkook listing resolves. The plain ointment is a quasi-drug and is sold at Daiso and convenience retailers as well as pharmacies; only the antibiotic-containing Madecassol Care Ointment, which holds a dated MFDS drug-approval record (2009-06-08, item code 200903973) at health.kr, is restricted to pharmacy sale. Because that variant contains neomycin sulfate, combining it with other topical treatments on broken skin without a pharmacist's guidance runs against the OTC labeling that keeps it off open shelves in the first place.